Related Experiment Videos
[Ulcerative colitis associated with chronic atrophic polychondritis. One case (author's transl)]
Summary
A 70-year-old male developed ulcerative colitis and chronic atrophic polychondritis. Polychondritis exacerbations preceded ulcerative colitis attacks, suggesting a link. Sulfone treatment showed promise for polychondritis.
Area of Science:
- Rheumatology
- Gastroenterology
- Immunology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Chronic atrophic polychondritis (CAP) is a rare systemic autoimmune disease affecting cartilage.
- The co-occurrence of UC and CAP is uncommon, prompting investigation into potential associations.
Observation:
- A 70-year-old male patient presented with ulcerative colitis.
- Nine months after the initial UC diagnosis, signs of chronic atrophic polychondritis emerged.
- Repeatedly, exacerbations of polychondritis preceded subsequent attacks of ulcerative colitis.
Findings:
- The temporal relationship suggests a potential causal link between polychondritis and ulcerative colitis, rather than mere coincidence.
- Sulfone therapy, at a daily dose of 200 mg, demonstrated satisfactory clinical response in managing polychondritis symptoms.
- The observed efficacy of sulfones requires further validation through additional clinical studies.
Implications:
- This case highlights a possible etiological connection between polychondritis and ulcerative colitis.
- Sulfones may represent a viable therapeutic option for managing polychondritis in patients with co-existing ulcerative colitis.
- Further research is warranted to elucidate the underlying mechanisms and confirm treatment efficacy.